JUPITER, Fla.--(BUSINESS WIRE)--BioRestorative Therapies, Inc. (“BRT” or the “Company”) (OTCBB:BRTX), a life sciences company focused on adult stem cell-based therapies for various personal medical applications, today announced that it has entered into a Research and Development Agreement (“Agreement”) with Rohto Pharmaceutical Company, Ltd. (“Rohto”). Under the Agreement, BRT has been engaged to provide stem cell research and development services.
Help employers find you! Check out all the jobs and post your resume.
